For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA0755Ha&default-theme=true
RNS Number : 0755H Morgan Advanced Materials PLC 01 May 2025
1 May
2025
Morgan Advanced Materials PLC (the "Company")
Voting Rights and Capital
The Company announces, in compliance with its obligations under Rules 5.6.1R
and 5.6.2G of the FCA's Disclosure Guidance and Transparency Rules, that as at
30 April 2025, the Company's share capital consisted of:
· 280,593,091 Ordinary shares of 25 pence each, with equal voting
rights; and
· 437,281 Cumulative Preference shares of £1.00 each, which do not
carry voting rights, save in specified limited circumstances.
The Company does not hold any shares in Treasury.
Since the commencement of the share buyback programme announced on 5 November
2024, the Company has purchased (and subsequently cancelled) 4,776,897
Ordinary shares.
The figure of 280,593,091 may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company's shares
under the Disclosure Guidance and Transparency Rules.
Contact:
Win Chime, Group Company Secretary
Morgan Advanced Materials plc
company.secretariat@morganplc.com (mailto:company.secretariat@morganplc.com)
The Company's LEI code is I4K14LL95N2PHDL7EG85.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVREAESFEFPSEFA